Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ
Closed
Oct 9, 2026
Day's Range
3.1952 wk Range
2.42Overview - IMDX - Insight Molecular Diagnostics Inc.
Key Statistics
Valuation
Enterprise Value
95.47M
P/E (Trailing)
‪-2.04‬
P/E (Forward)
‪-4.04‬
PEG Ratio
‪-0.61‬
Price / Sales (TTM)
‪63.48‬
Price / Book
‪-5.81‬
EV / EBITDA
‪-2.76‬
Profitability
Gross Margin
‪65.69%‬
Profit Margin
‪56.67%‬
Operating Margin
‪-3,815.06%‬
Return on Assets
‪-57.82%‬
Return on Equity
‪159.61%‬
Ownership
Shares Outstanding
32.62M
Float
9.97M
Short % of Shares Outstanding
‪6.10%‬
Held by Insiders
‪20.99%‬
Held by Institutions
‪56.42%‬
Price stats
Beta
‪1.80‬
50-Day Avg
‪4.14‬
200-Day Avg
‪5.05‬
Analyst Consensus
5 analysts
Average price target
‪$ 8.33‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - IMDX - Insight Molecular Diagnostics Inc.
Peers - IMDX - Insight Molecular Diagnostics Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- IMDXNASDAQInsight Molecular Diagnostics Inc.110.28MMarket Cap-15.43%52-week change-2.04P/E (Trailing)‪56.67%‬Profit Margin
- NTRANASDAQNatera, Inc.59.14BMarket Cap+58.48%52-week change-269.84P/E (Trailing)‪-7.10%‬Profit Margin
- ILMNNASDAQIllumina Inc.41.22BMarket Cap+63.00%52-week change50.85P/E (Trailing)‪18.33%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.40.86BMarket Cap-22.26%52-week change36.06P/E (Trailing)‪25.03%‬Profit Margin
- GHNASDAQGuardant Health Inc.23.86BMarket Cap+64.35%52-week change-53.55P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings, Inc.16.86BMarket Cap+14.16%52-week change35.48P/E (Trailing)‪17.66%‬Profit Margin
- ICLRNASDAQICON plc12.50BMarket Cap-17.51%52-week change170.58P/E (Trailing)‪0.32%‬Profit Margin
Profile Summary - IMDX - Insight Molecular Diagnostics Inc.
About
Insight Molecular Diagnostics Inc. is a molecular diagnostics company focused on precision testing for transplantation and oncology. The company develops and commercializes laboratory-developed, kitted research-use, and clinical diagnostic tests that help clinicians assess organ rejection, monitor therapeutic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
